Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver

The nuclear receptor PPARalpha is activated by drugs to treat human disorders of lipid metabolism. Its endogenous ligand is unknown. PPARalpha-dependent gene expression is impaired with inactivation of fatty acid synthase (FAS), suggesting that FAS is involved in generation of a PPARalpha ligand. Here we demonstrate the FAS-dependent presence of a phospholipid bound to PPARalpha isolated from mouse liver. Binding was increased under conditions that induce FAS activity and displaced by systemic injection of a PPARalpha agonist. Mass spectrometry identified the species as 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Knockdown of Cept1, required for phosphatidylcholine synthesis, suppressed PPARalpha-dependent gene expression. Interaction of 16:0/18:1-GPC with the PPARalpha ligand-binding domain and coactivator peptide motifs was comparable to PPARalpha agonists, but interactions with PPARdelta were weak and none were detected with PPARgamma. Portal vein infusion of 16:0/18:1-GPC induced PPARalpha-dependent gene expression and decreased hepatic steatosis. These data suggest that 16:0/18:1-GPC is a physiologically relevant endogenous PPARalpha ligand.

[1]  Xianlin Han,et al.  Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene* , 2003, Journal of Biological Chemistry.

[2]  C. Kent.  Regulatory enzymes of phosphatidylcholine biosynthesis: a personal perspective. , 2005, Biochimica et biophysica acta.

[3]  B. Staels,et al.  Oxidized phospholipids activate PPARα in a phospholipase A2‐dependent manner , 2000 .

[4]  T. Giese,et al.  Anti-inflammatory Effects of Phosphatidylcholine* , 2007, Journal of Biological Chemistry.

[5]  D. Ford,et al.  Characterization of alkylacyl, alk-1-enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization. , 2003, Journal of mass spectrometry : JMS.

[6]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[7]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[8]  C. Semenkovich,et al.  PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. , 2002, Journal of lipid research.

[9]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[10]  B. Staels,et al.  Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. , 2000, FEBS letters.

[11]  H. Xu,et al.  Molecular recognition of parathyroid hormone by its G protein-coupled receptor , 2008, Proceedings of the National Academy of Sciences.

[12]  S. Kliewer,et al.  Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. , 2005, Molecular cell.

[13]  B. M. Forman.  Are those phospholipids in your pocket? , 2005, Cell metabolism.

[14]  Kai Yu,et al.  Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (*) , 1995, The Journal of Biological Chemistry.

[15]  R. Watson,et al.  Gapex-5, a Rab31 guanine nucleotide exchange factor that regulates Glut4 trafficking in adipocytes. , 2007, Cell metabolism.

[16]  T Hashimoto,et al.  Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. , 2001, Annual review of nutrition.

[17]  A. Vollmer,et al.  Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. , 1995, Hypertension.

[18]  Jasmine Chen,et al.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Blanchard,et al.  Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. , 1998, Analytical biochemistry.

[20]  J. Turk,et al.  Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis. , 1998, Biochemistry.

[21]  D. Vance,et al.  The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. , 2006, Cell metabolism.

[22]  J. Lehmann,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Mazzon,et al.  Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in mice , 2004, Laboratory Investigation.

[24]  R. Gillilan,et al.  Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4. , 2007, Biochemistry.

[25]  Barry M. Forman,et al.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .

[26]  R. Evans,et al.  The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Willson,et al.  Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1 , 2005, Cell.

[28]  R. Evans,et al.  Role for Peroxisome Proliferator-Activated Receptor &agr; in Oxidized Phospholipid–Induced Synthesis of Monocyte Chemotactic Protein-1 and Interleukin-8 by Endothelial Cells , 2000, Circulation research.

[29]  J. C. Hinshaw,et al.  Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists* , 2001, The Journal of Biological Chemistry.

[30]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[31]  R. Knutsen,et al.  Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice , 2003, Nature Medicine.

[32]  C. Semenkovich,et al.  Regulation of fatty acid synthase (FAS). , 1997, Progress in lipid research.

[33]  G. Lichtenstein.  Phosphatidylcholine for Steroid-Refractory Chronic Ulcerative Colitis: A Randomized Trial , 2008 .

[34]  J. Bruggink,et al.  Hepatic Portal Vein Cannulation for Infusion and Blood Sampling in Freely Moving Rats , 1998, Physiology & Behavior.

[35]  C. Mansbach,et al.  Portal transport of long acyl chain lipids: effect of phosphatidylcholine and low infusion rates. , 1993, The American journal of physiology.

[36]  C. Glass,et al.  Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. , 2007, Trends in immunology.

[37]  D. Moras,et al.  Crystal Structure of the Ligand-binding Domain of the Ultraspiracle Protein USP, the Ortholog of Retinoid X Receptors in Insects* , 2001, The Journal of Biological Chemistry.

[38]  Yanhong Shi,et al.  The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Barter,et al.  Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[40]  M. Lane,et al.  Brain fatty acid synthase activates PPARα to maintain energy homeostasis , 2007 .

[41]  P. Hart,et al.  Metabolism of Glycerolipids , 2003 .

[42]  D. Bredt,et al.  Identification and Characterization of a Major Liver Lysophosphatidylcholine Acyltransferase* , 2008, Journal of Biological Chemistry.

[43]  M. Lane,et al.  Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. , 2007, The Journal of clinical investigation.

[44]  F. Hsu,et al.  Formation of lithiated adducts of glycerophosphocholine lipids facilitates their identification by electrospray ionization tandem mass spectrometry , 1998, Journal of the American Society for Mass Spectrometry.

[45]  任艳,et al.  胰岛素增敏剂一Thiazolidinediones研究现状 , 2000 .

[46]  W. Lands.  Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin. , 1960, The Journal of biological chemistry.

[47]  Janet Hager,et al.  Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP , 2005, Nature Structural &Molecular Biology.

[48]  John Turk,et al.  Electrospray ionization/tandem quadrupole mass spectrometric studies on phosphatidylcholines: The fragmentation processes , 2003, Journal of the American Society for Mass Spectrometry.

[49]  C. McMaster,et al.  The major sites of cellular phospholipid synthesis and molecular determinants of Fatty Acid and lipid head group specificity. , 2002, Molecular biology of the cell.

[50]  T. Willson,et al.  Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men , 2008, Diabetes.

[51]  A. Scheurink,et al.  Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. , 2000, American journal of physiology. Endocrinology and metabolism.

[52]  N. Ridgway,et al.  Regulation of the CDP-choline pathway by sterol regulatory element binding proteins involves transcriptional and post-transcriptional mechanisms. , 2003, The Biochemical journal.

[53]  J. Turk,et al.  Mass Spectrometric Evidence That Agents That Cause Loss of Ca 2؉ from Intracellular Compartments Induce Hydrolysis of Arachidonic Acid from Pancreatic Islet Membrane Phospholipids by a Mechanism That Does Not Require a Rise in Cytosolic Ca 2؉ Concentration* , 2022 .

[54]  F. Hsu,et al.  Structural determination of sphingomyelin by tandem mass spectrometry with electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[55]  A. Cantafora,et al.  Effect of intravenous polyunsaturated phosphatidylcholine infusion on insulin receptor processing and lipid composition of erythrocytes in patients with liver cirrhosis , 1992, European journal of clinical investigation.

[56]  T. Hashimoto,et al.  PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .